{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:23:33Z","timestamp":1791998613958,"version":"4.4.0"},"reference-count":100,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Fondazione Cassa di Risparmio di Fabriano e Cupramontana"},{"name":"Italian Ministry of the University and Research","award":["20102CHST5_007"],"award-info":[{"award-number":["20102CHST5_007"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","bestpracticeobgyn.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Obstetrics & Gynaecology"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.bpobgyn.2015.08.018","type":"journal-article","created":{"date-parts":[[2015,9,26]],"date-time":"2015-09-26T00:58:41Z","timestamp":1443229121000},"page":"25-36","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["Growth factors and pathogenesis"],"prefix":"10.1016","volume":"34","author":[{"given":"Md Soriful","family":"Islam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Greco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milijana","family":"Janjusevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Ciavattini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano Raffaele","family":"Giannubilo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Assunta","family":"D'Adderio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Biagini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosamaria","family":"Fiorini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Castellucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4400-3786","authenticated-orcid":false,"given":"Pasquapina","family":"Ciarmela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpobgyn.2015.08.018_bib1","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1210\/jc.2012-3237","article-title":"Uterine leiomyoma: available medical treatments and new possible therapeutic options","volume":"98","author":"Islam","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib2","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0015-0282(16)45789-4","article-title":"Uterine leiomyomata: etiology, symptomatology, and management","volume":"36","author":"Buttram","year":"1981","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib3","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1093\/ajcp\/94.4.435","article-title":"The frequency of uterine leiomyomas","volume":"94","author":"Cramer","year":"1990","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib4","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.fertnstert.2013.03.007","article-title":"Complex networks of multiple factors in the pathogenesis of uterine leiomyoma","volume":"100","author":"Islam","year":"2013","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib5","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1093\/humupd\/dmr031","article-title":"Growth factors and myometrium: biological effects in uterine fibroid and possible clinical implications","volume":"17","author":"Ciarmela","year":"2011","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib6","doi-asserted-by":"crossref","first-page":"E775","DOI":"10.1210\/jc.2013-2623","article-title":"Role of activin-A and myostatin and their signaling pathway in human myometrial and leiomyoma cell function","volume":"99","author":"Islam","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib7","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1095\/biolreprod.108.075887","article-title":"Reactive oxygen species mediate mitogenic growth factor signaling pathways in human leiomyoma smooth muscle cells","volume":"82","author":"Mesquita","year":"2010","journal-title":"Biol Reprod"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib8","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1073\/pnas.1215759110","article-title":"Loss of the repressor REST in uterine fibroids promotes aberrant G protein-coupled receptor 10 expression and activates mammalian target of rapamycin pathway","volume":"110","author":"Varghese","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib9","doi-asserted-by":"crossref","first-page":"17053","DOI":"10.1073\/pnas.1313650110","article-title":"Paracrine activation of WNT\/\u03b2-catenin pathway in uterine leiomyoma stem cells promotes tumor growth","volume":"110","author":"Ono","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib10","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1210\/jc.2010-0501","article-title":"Activin-A and myostatin response and steroid regulation in human myometrium: disruption of their signalling in uterine fibroid","volume":"96","author":"Ciarmela","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib11","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.biochi.2005.07.014","article-title":"Fibroblast growth factors (FGF) in human myometrium and uterine leiomyomas in various stages of tumour growth","volume":"88","author":"Wolanska","year":"2006","journal-title":"Biochimie"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib12","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1095\/biolreprod53.3.636","article-title":"Isolation and characterization of heparin-binding growth factors in human leiomyomas and normal myometrium","volume":"53","author":"Mangrulkar","year":"1995","journal-title":"Biol Reprod"},{"issue":"Suppl. 5","key":"10.1016\/j.bpobgyn.2015.08.018_bib13","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1289\/ehp.00108s5795","article-title":"Immunohistochemical localization of growth factors and their receptors in uterine leiomyomas and matched myometrium","volume":"108","author":"Dixon","year":"2000","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib14","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1038\/bjc.1997.278","article-title":"Expression of insulin-like growth factors (IGFs), their receptors and IGF binding protein-3 in normal, benign and malignant smooth muscle tissues","volume":"75","author":"Van der Ven","year":"1997","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib15","doi-asserted-by":"crossref","first-page":"28","DOI":"10.4161\/cbt.5.1.2234","article-title":"Expression and functional analysis of platelet-derived growth factor in uterine leiomyomata","volume":"5","author":"Liang","year":"2006","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib16","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/molehr\/3.3.233","article-title":"The expression of transforming growth factor-beta s and TGF-beta receptor mRNA and protein and the effect of TGF-beta s on human myometrial smooth muscle cells in\u00a0vitro","volume":"3","author":"Tang","year":"1997","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib17","first-page":"3222","article-title":"Suppression of transforming growth factor-beta (TGF beta) and TGF beta receptor messenger ribonucleic acid and protein expression in leiomyomata in women receiving gonadotropin-releasing hormone agonist therapy","volume":"81","author":"Dou","year":"1996","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib18","first-page":"1853","article-title":"Localization and quantification of vascular endothelial growth factor messenger ribonucleic acid in human myometrium and leiomyomata","volume":"80","author":"Harrison-Woolrych","year":"1995","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib19","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1042\/cs1010691","article-title":"Quantification of vascular endothelial growth factor-A in leiomyomas and adjacent myometrium","volume":"101","author":"Gentry","year":"2001","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib20","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/321776a0","article-title":"Purification and characterization of an FSH releasing protein from porcine ovarian follicular fluid","volume":"321","author":"Vale","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib21","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.cytogfr.2006.01.001","article-title":"Roles of activin in tissue repair, fibrosis, and inflammatory disease","volume":"17","author":"Werner","year":"2006","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib22","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1478-811X-7-15","article-title":"Activin signaling as an emerging target for therapeutic interventions","volume":"7","author":"Tsuchida","year":"2009","journal-title":"Cell Commun Signal"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib23","doi-asserted-by":"crossref","first-page":"40788","DOI":"10.1074\/jbc.M006114200","article-title":"Identification and characterization of a novel follistatin-like protein as a binding protein for the TGF-\u00ce\u00b2 family","volume":"275","author":"Tsuchida","year":"2000","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib24","doi-asserted-by":"crossref","first-page":"40735","DOI":"10.1074\/jbc.M206379200","article-title":"The myostatin propeptide and the follistatin-related gene are inhibitory binding proteins of myostatin in normal serum","volume":"277","author":"Hill","year":"2002","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib25","doi-asserted-by":"crossref","first-page":"4490","DOI":"10.1074\/jbc.M704960200","article-title":"Cripto is a noncompetitive activin antagonist that forms analogous signaling complexes with activin and nodal","volume":"283","author":"Kelber","year":"2008","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib26","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1210\/endo.142.3.8028","article-title":"Regulation and actions of Smad7 in the modulation of activin, inhibin, and transforming growth factor-beta signaling in anterior pituitary cells","volume":"142","author":"Bilezikjian","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib27","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1210\/en.2007-0692","article-title":"Activin-A in myometrium: characterization of the actions on myometrial cells","volume":"149","author":"Ciarmela","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib28","doi-asserted-by":"crossref","DOI":"10.1177\/1933719115592710","article-title":"Expression levels of myostatin and matrix metalloproteinase 14 mRNAs in uterine leiomyoma are correlated with dysmenorrhea","author":"Tsigkou","year":"2015","journal-title":"Reprod Sci"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib29","first-page":"2808","article-title":"Expression of the hypoxically regulated angiogenic factor adrenomedullin correlates with uterine leiomyoma vascular density","volume":"6","author":"Hague","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib30","doi-asserted-by":"crossref","first-page":"264","DOI":"10.2119\/2007-00101.Yu","article-title":"Differential expression of receptor tyrosine kinases (RTKs) and IGF-I pathway activation in human uterine leiomyomas","volume":"14","author":"Yu","year":"2008","journal-title":"Mol Med"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib31","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/0002-9378(95)90284-8","article-title":"Mitogenic effect of basic fibroblast growth factor and estradiol on cultured human myometrial and leiomyoma cells","volume":"173","author":"Rauk","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib32","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/S0015-0282(16)54681-0","article-title":"Presence of messenger ribonucleic acid for epidermal growth factor (EGF) and EGF receptor demonstrable in monolayer cell cultures of myometria and leiomyomata","volume":"56","author":"Yeh","year":"1991","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib33","first-page":"30","article-title":"Human uterine leiomyoma cells: binding and growth responses to epidermal growth factor, platelet-derived growth factor, and insulin","volume":"60","author":"Fayed","year":"1989","journal-title":"Lab Invest"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib34","first-page":"1716","article-title":"Presence of epidermal growth factor, platelet-derived growth factor, and their receptors in human myometrial tissue and smooth muscle cells: their action in smooth muscle cells in\u00a0vitro","volume":"130","author":"Rossi","year":"1992","journal-title":"Endocrinology"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib35","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.fertnstert.2011.07.004","article-title":"Different effects of epidermal growth factor on smooth muscle cells derived from human myometrium and from leiomyoma","volume":"96","author":"Ren","year":"2011","journal-title":"Fertil Steril"},{"issue":"Suppl. 5","key":"10.1016\/j.bpobgyn.2015.08.018_bib36","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1289\/ehp.00108s5849","article-title":"Novel therapeutic strategies for leiomyomas: targeting growth factors and their receptors","volume":"108","author":"Nowak","year":"2000","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib37","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1093\/humrep\/deh842","article-title":"Comparative effects of heparin-binding epidermal growth factor-like growth factor on the growth of cultured human uterine leiomyoma cells and myometrial cells","volume":"20","author":"Wang","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib38","first-page":"6689","article-title":"Insulin-like growth factor gene expression in human smooth muscle tumors","volume":"50","author":"Gloudemans","year":"1990","journal-title":"Cancer Res"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib39","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1016\/0002-9378(95)91420-X","article-title":"Insulin-like growth factor I promotes leiomyoma cell growth in\u00a0vitro","volume":"172","author":"Strawn","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib40","doi-asserted-by":"crossref","first-page":"5593","DOI":"10.1210\/jcem.86.11.8008","article-title":"Up-regulation by IGF-I of proliferating cell nuclear antigen and Bcl-2 protein expression in human uterine leiomyoma cells","volume":"86","author":"Gao","year":"2001","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib41","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1016\/j.fertnstert.2007.10.083","article-title":"Expression of insulin-like growth factors (IGFs) and IGF signaling: molecular complexity in uterine leiomyomas","volume":"91","author":"Peng","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib42","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.cyto.2004.03.007","article-title":"Myostatin signaling through Smad2, Smad3 and Smad4 is regulated by the inhibitory Smad7 by a negative feedback mechanism","volume":"26","author":"Zhu","year":"2004","journal-title":"Cytokine"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib43","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1210\/en.2008-0880","article-title":"Presence, actions, and regulation of myostatin in rat uterus and myometrial cells","volume":"150","author":"Ciarmela","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib44","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/mrd.1080270203","article-title":"Expression of the insulin-like and platelet-derived growth factor genes in human uterine tissues","volume":"27","author":"Boehm","year":"1990","journal-title":"Mol Reprod Dev"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib45","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.fertnstert.2007.02.031","article-title":"Increased expression of platelet-derived growth factor C messenger ribonucleic acid in uterine leiomyomata","volume":"89","author":"Hwu","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib46","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1095\/biolreprod.109.076869","article-title":"Platelet-derived growth factor C is upregulated in human uterine fibroids and regulates uterine smooth muscle cell growth","volume":"81","author":"Suo","year":"2009","journal-title":"Biol Reprod"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib47","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1067\/mob.2003.118","article-title":"Expression, menstrual cycle-dependent activation, and bimodal mitogenic effect of transforming growth factor-beta1 in human myometrium and leiomyoma","volume":"188","author":"Arici","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib48","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1677\/joe.0.1690079","article-title":"Human uterine myometrial smooth muscle cell proliferation and vascular endothelial growth-factor production in response to platelet-derived growth factor","volume":"169","author":"Taniguchi","year":"2001","journal-title":"J\u00a0Endocrinol"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib49","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ejogrb.2006.01.034","article-title":"Transforming growth factor beta and platelet-derived growth factor in human myometrium and in uterine leiomyomas at various stages of tumour growth","volume":"130","author":"Wolanska","year":"2007","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib50","doi-asserted-by":"crossref","first-page":"13606","DOI":"10.1016\/S0021-9258(17)43958-5","article-title":"Epidermal growth factor-like transforming growth factor. I. Isolation, chemical characterization, and potentiation by other transforming factors from feline sarcoma virus-transformed rat cells","volume":"258","author":"Massague","year":"1983","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib51","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0940-2993(00)80028-7","article-title":"Transforming growth factor-alpha, epidermal growth factor receptor, and PCNA immunoexpression in uterine leiomyosarcomas and leiomyomas in B6C3F1 mice","volume":"52","author":"Moore","year":"2000","journal-title":"Exp Toxicol Pathol"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib52","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1146\/annurev.biochem.67.1.753","article-title":"TGF-beta signal transduction","volume":"67","author":"Massagu\u00e9","year":"1998","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib53","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nature02006","article-title":"Smad-dependent and Smad-independent pathways in TGF-beta family signalling","volume":"425","author":"Derynck","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib54","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.mce.2003.08.007","article-title":"The expression of Smads and transforming growth factor beta receptors in leiomyoma and myometrium and the effect of gonadotropin releasing hormone analogue therapy","volume":"209","author":"Chegini","year":"2003","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib55","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1210\/jc.2002-021325","article-title":"Differential expression, regulation, and induction of Smads, transforming growth factor-beta signal transduction pathway in leiomyoma, and myometrial smooth muscle cells and alteration by gonadotropin-releasing hormone analog","volume":"88","author":"Xu","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib56","doi-asserted-by":"crossref","first-page":"5549","DOI":"10.1210\/jc.2004-0161","volume":"89","author":"Ding","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib57","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1210\/en.2004-1377","article-title":"Gene expression profiling of leiomyoma and myometrial smooth muscle cells in response to transforming growth factor-beta","volume":"146","author":"Luo","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib58","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/molehr\/gal015","article-title":"CCNs, fibulin-1C and S100A4 expression in leiomyoma and myometrium: inverse association with TGF-beta and regulation by TGF-beta in leiomyoma and myometrial smooth muscle cells","volume":"12","author":"Luo","year":"2006","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib59","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/molehr\/gah187","article-title":"Fibromodulin is expressed in leiomyoma and myometrium and regulated by gonadotropin-releasing hormone analogue therapy and TGF-beta through Smad and MAPK-mediated signalling","volume":"11","author":"Levens","year":"2005","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib60","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S0015-0282(00)00418-0","article-title":"Transforming growth factor-beta3 is expressed at high levels in leiomyoma where it stimulates fibronectin expression and cell proliferation","volume":"73","author":"Arici","year":"2000","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib61","first-page":"913","article-title":"Human leiomyoma smooth muscle cells show increased expression of transforming growth factor-beta 3 (TGF beta 3) and altered responses to the antiproliferative effects of TGF beta","volume":"86","author":"Lee","year":"2001","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib62","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/j.fertnstert.2009.01.081","article-title":"Myometrial cells undergo fibrotic transformation under the influence of transforming growth factor beta-3","volume":"93","author":"Joseph","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib63","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1177\/1933719109343310","article-title":"Transforming growth factor beta3 regulates the versican variants in the extracellular matrix-rich uterine leiomyomas","volume":"16","author":"Norian","year":"2009","journal-title":"Reprod Sci"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib64","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1210\/edrv-13-1-18","article-title":"Molecular and biological properties of the vascular endothelial growth factor family of proteins","volume":"13","author":"Ferrara","year":"1992","journal-title":"Endocr Rev"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2008.02.010","article-title":"Memy I: a novel murine model for uterine leiomyoma using adenovirus-enhanced human fibroid explants in severe combined immune deficiency mice","volume":"199","author":"Hassan","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib66","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.acthis.2010.01.001","article-title":"Immunolocalization of VEGF, VEGF receptors, EGF-R and Ki-67 in leiomyoma, cellular leiomyoma and leiomyosarcoma","volume":"113","author":"Sanci","year":"2011","journal-title":"Acta Histochem"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib67","first-page":"245","article-title":"Uterine smooth muscle cells express functional receptors (flt-1 and KDR) for vascular permeability factor\/vascular endothelial growth factor","volume":"76","author":"Brown","year":"1997","journal-title":"Lab Invest"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib68","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0029-7844(95)00102-W","article-title":"GnRH agonist and iron versus placebo and iron in the anemic patient before surgery for leiomyomas: a randomized controlled trial. The Leuprolide Study Group","volume":"86","author":"Stovall","year":"1995","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib69","first-page":"720","article-title":"Treatment of leiomyomata uteri with leuprolide acetate depot: a double-blind, placebo-controlled, multicenter study. The Leuprolide Study Group","volume":"77","author":"Friedman","year":"1991","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib70","first-page":"104","article-title":"The prevention of bone loss in young women treated with GnRH analogues with\u201c add-back\u201d estrogen therapy","volume":"81","author":"Leather","year":"1993","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib71","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/molehr\/gah002","article-title":"Molecular mechanisms involved in GnRH analogue-related apoptosis for uterine leiomyomas","volume":"10","author":"Bifulco","year":"2004","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib72","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1071-5576(02)00184-3","article-title":"Gonadotropin releasing hormone analogue therapy alters signal transduction pathways involving mitogen-activated protein and focal adhesion kinases in leiomyoma","volume":"10","author":"Chegini","year":"2003","journal-title":"J\u00a0Soc Gynecol Investig"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib73","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.steroids.2004.10.008","article-title":"Preoperative administration of GnRH-a plus tibolone to premenopausal women with uterine fibroids: evaluation of the clinical response, the immunohistochemical expression of PDGF, bFGF and VEGF and the vascular pattern","volume":"70","author":"Di Lieto","year":"2005","journal-title":"Steroids"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib74","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1053\/hupa.2002.31298","article-title":"Relationship between platelet-derived growth factor expression in leiomyomas and uterine volume changes after gonadotropin-releasing hormone agonist treatment","volume":"33","author":"Di Lieto","year":"2002","journal-title":"Hum Pathol"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib75","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1517\/17425255.2012.695775","article-title":"Pharmacokinetic evaluation of ulipristal acetate for uterine leiomyoma treatment","volume":"8","author":"Melis","year":"2012","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib76","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1056\/NEJMoa1103180","article-title":"Ulipristal acetate versus.euprolide acetate for uterine fibroids","volume":"366","author":"Donnez","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib77","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1056\/NEJMoa1103182","article-title":"Ulipristal acetate versus placebo for fibroid treatment before surgery","volume":"366","author":"Donnez","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2014.10.038","article-title":"Efficacy and safety of repeated use of ulipristal acetate in uterine fibroids","volume":"103","author":"Donnez","year":"2015","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib79","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1177\/1933719114542019","article-title":"Ulipristal acetate modulates the expression and functions of activin A in leiomyoma cells","volume":"21","author":"Ciarmela","year":"2014","journal-title":"Reprod Sci"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib80","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1093\/humrep\/del159","article-title":"Progesterone receptor modulator CDB-2914 down-regulates vascular endothelial growth factor, adrenomedullin and their receptors and modulates progesterone receptor content in cultured human uterine leiomyoma cells","volume":"21","author":"Xu","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib81","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1093\/molehr\/gan004","article-title":"Progesterone receptor modulator CDB-2914 induces extracellular matrix metalloproteinase inducer in cultured human uterine leiomyoma cells","volume":"14","author":"Xu","year":"2008","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib82","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1210\/jc.2004-1569","article-title":"Progesterone receptor modulator CDB-2914 down-regulates proliferative cell nuclear antigen and Bcl-2 protein expression and up-regulates caspase-3 and poly (adenosine 5'-diphosphate-ribose) polymerase expression in cultured human uterine leiomyoma cells","volume":"90","author":"Xu","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib83","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1080\/01635580903285163","article-title":"Genistein suppresses spontaneous oviduct tumorigenesis in Quail","volume":"61","author":"Sahin","year":"2009","journal-title":"Nutr Cancer"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib84","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1093\/humrep\/dem185","article-title":"Stimulatory and inhibitory effects of genistein on human uterine leiomyoma cell proliferation are influenced by the concentration","volume":"22","author":"Moore","year":"2007","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib85","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3858\/emm.2012.44.4.024","article-title":"A\u00a0high concentration of genistein down-regulates activin A, Smad3 and other TGF-\u03b2 pathway genes in human uterine leiomyoma cells","volume":"44","author":"Di","year":"2012","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib86","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1016\/j.fertnstert.2008.03.045","article-title":"Curcumin, a nutritional supplement with antineoplastic activity, enhances leiomyoma cell apoptosis and decreases fibronectin expression","volume":"91","author":"Malik","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib87","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.fertnstert.2014.05.013","article-title":"Tranilast, an orally active antiallergic compound, inhibits extracellular matrix production in human uterine leiomyoma and myometrial cells","volume":"102","author":"Islam","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib88","doi-asserted-by":"crossref","first-page":"5610","DOI":"10.1210\/jc.2002-020444","article-title":"Tranilast inhibits the proliferation of uterine leiomyoma cells in\u00a0vitro through G1 arrest associated with the induction of p21waf1 and p53","volume":"87","author":"Shime","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib89","first-page":"321","article-title":"Antiproliferative effect of tranilast on human myometrial and leiomyoma cells","volume":"2","author":"Islam","year":"2012","journal-title":"Biol Biomed Rep"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib90","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1095\/biolreprod.111.098145","article-title":"1,25-dihydroxyvitamin D3 treatment shrinks uterine leiomyoma tumors in the Eker rat model","volume":"86","author":"Halder","year":"2012","journal-title":"Biol Reprod"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib91","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1016\/j.fertnstert.2008.02.136","article-title":"Vitamin D inhibits myometrial and leiomyoma cell proliferation in\u00a0vitro","volume":"91","author":"Bl\u00e4uer","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib92","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.fertnstert.2010.07.1041","article-title":"Vitamin D inhibits proliferation of human uterine leiomyoma cells via catechol-O-methyltransferase","volume":"95","author":"Sharan","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib93","doi-asserted-by":"crossref","first-page":"E754","DOI":"10.1210\/jc.2010-2131","article-title":"1,25-Dihydroxyvitamin D reduces TGF-\u03b23-induced fibrosis-related gene expression in human uterine leiomyoma cells","volume":"96","author":"Halder","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib94","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1093\/humrep\/deh355","article-title":"The AG1478 tyrosine kinase inhibitor is an effective suppressor of leiomyoma cell growth","volume":"19","author":"Shushan","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib95","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.fertnstert.2006.05.056","article-title":"Inhibition of leiomyoma cell proliferation in\u00a0vitro by genistein and the protein tyrosine kinase inhibitor TKS050","volume":"87","author":"Shushan","year":"2007","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib96","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1158\/1078-0432.CCR-06-1811","article-title":"Tumor-specific efficacy of transforming growth factor-beta RI inhibition in Eker rats","volume":"13","author":"Laping","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib97","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1210\/jc.2008-2093","article-title":"Progestins activate the AKT pathway in leiomyoma cells and promote survival","volume":"94","author":"Hoekstra","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib98","doi-asserted-by":"crossref","first-page":"4046","DOI":"10.1210\/en.2013-1389","article-title":"MK-2206, an AKT Inhibitor, promotes caspase-independent cell death and inhibits leiomyoma growth","volume":"154","author":"Sefton","year":"2013","journal-title":"Endocrinology"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib99","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2006.09.037","article-title":"Requirements of phosphatidylinositol-3 kinase and mammalian target of rapamycin for estrogen-induced proliferation in uterine leiomyoma-and myometrium-derived cell lines","volume":"196","author":"Yin","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2015.08.018_bib100","doi-asserted-by":"crossref","first-page":"6171","DOI":"10.1158\/0008-5472.CAN-08-4471","article-title":"Comparison of human and rat uterine leiomyomata: identification of a dysregulated mammalian target of rapamycin pathway","volume":"69","author":"Crabtree","year":"2009","journal-title":"Cancer Res"}],"container-title":["Best Practice & Research Clinical Obstetrics & Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693415001649?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693415001649?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,22]],"date-time":"2022-05-22T09:04:03Z","timestamp":1653210243000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521693415001649"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":100,"alternative-id":["S1521693415001649"],"URL":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2015.08.018","relation":{},"ISSN":["1521-6934"],"issn-type":[{"value":"1521-6934","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Growth factors and pathogenesis","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Obstetrics & Gynaecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2015.08.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}